Access

Business

Nature 439, 390-391 (26 January 2006) | doi:10.1038/439390a; Published online 25 January 2005

The right combination

Top

Instead of the painstaking process of developing new drugs, one Boston-based company is making its mark by pairing up those we already have. Meredith Wadman reports.

Drug research largely boils down to the search for 'magic bullets' — molecules that act against single, specific biological targets. But putting each candidate bullet through its paces is a laborious and expensive business.

You have created an error.